1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: Thin-1, NCT01379742
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: 40 to 90 Sponsor: Other Protocol IDs: 02-4407-V04, NCT00486499
|
|
3.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000698986, ACOSOG-Z4099, ACOSOG-Z4099/RTOG-1021, NCT01336894
|
|
4.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000533887, RTOG-0526, NCT00450411
|
|
5.
|
Phase: Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-0366, NCT01460810
|
|
6.
|
Phase: No phase specified Type: Diagnostic Status: Active Age: Over 18 Sponsor: Other Protocol IDs: CCR3047, NCT00749697
|
|
7.
|
Phase: No phase specified Type: Educational/Counseling/Training, Treatment Status: Active Age: Adult Sponsor: Other Protocol IDs: CDR0000668741, USCTU-SABRE1, ISRCTN88144169, EU-21018, CRUK-CTAAC-C328/A8692, NCRN-11061813, US-SABRE 1, NCT01098331
|